vs

Side-by-side financial comparison of Apyx Medical Corp (APYX) and SOUTHERN FIRST BANCSHARES INC (SFST). Click either name above to swap in a different company.

SOUTHERN FIRST BANCSHARES INC is the larger business by last-quarter revenue ($31.8M vs $19.2M, roughly 1.7× Apyx Medical Corp). On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs 26.1%). SOUTHERN FIRST BANCSHARES INC produced more free cash flow last quarter ($29.9M vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 22.2%).

Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.

First Community Bankshares, Inc. is a $2.43 billion bank holding company and the parent company of First Community Bank of Bluefield, Virginia, in the United States. As of 2012 First Community Bank had 45 locations in Virginia, West Virginia, and North Carolina, and two locations operating as Peoples Community Bank in Tennessee. As of April 21, 2023, First Community had $3.6 billion in assets.

APYX vs SFST — Head-to-Head

Bigger by revenue
SFST
SFST
1.7× larger
SFST
$31.8M
$19.2M
APYX
Growing faster (revenue YoY)
APYX
APYX
+8.6% gap
APYX
34.7%
26.1%
SFST
More free cash flow
SFST
SFST
$32.7M more FCF
SFST
$29.9M
$-2.8M
APYX
Faster 2-yr revenue CAGR
APYX
APYX
Annualised
APYX
36.8%
22.2%
SFST

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
APYX
APYX
SFST
SFST
Revenue
$19.2M
$31.8M
Net Profit
$-1.3M
Gross Margin
62.6%
Operating Margin
0.1%
40.1%
Net Margin
-6.8%
Revenue YoY
34.7%
26.1%
Net Profit YoY
71.9%
EPS (diluted)
$1.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APYX
APYX
SFST
SFST
Q4 25
$19.2M
$31.8M
Q3 25
$12.9M
$31.1M
Q2 25
$11.4M
$28.6M
Q1 25
$9.4M
$26.5M
Q4 24
$14.2M
$25.2M
Q3 24
$11.5M
$23.8M
Q2 24
$12.1M
$23.1M
Q1 24
$10.2M
$21.3M
Net Profit
APYX
APYX
SFST
SFST
Q4 25
$-1.3M
Q3 25
$-2.0M
$8.7M
Q2 25
$-3.8M
$6.6M
Q1 25
$-4.2M
$5.3M
Q4 24
$-4.6M
Q3 24
$-4.7M
$4.4M
Q2 24
$-6.6M
$3.0M
Q1 24
$-7.6M
$2.5M
Gross Margin
APYX
APYX
SFST
SFST
Q4 25
62.6%
Q3 25
64.4%
Q2 25
62.3%
Q1 25
60.1%
Q4 24
63.0%
Q3 24
60.5%
Q2 24
61.7%
Q1 24
58.1%
Operating Margin
APYX
APYX
SFST
SFST
Q4 25
0.1%
40.1%
Q3 25
-6.5%
36.4%
Q2 25
-22.6%
30.0%
Q1 25
-32.4%
26.1%
Q4 24
-21.4%
27.3%
Q3 24
-31.6%
24.1%
Q2 24
-45.7%
17.0%
Q1 24
-64.6%
15.9%
Net Margin
APYX
APYX
SFST
SFST
Q4 25
-6.8%
Q3 25
-15.4%
27.8%
Q2 25
-33.2%
23.0%
Q1 25
-44.0%
19.9%
Q4 24
-32.5%
Q3 24
-40.9%
18.4%
Q2 24
-54.0%
13.0%
Q1 24
-74.0%
11.8%
EPS (diluted)
APYX
APYX
SFST
SFST
Q4 25
$1.19
Q3 25
$1.07
Q2 25
$0.81
Q1 25
$0.65
Q4 24
$0.69
Q3 24
$0.54
Q2 24
$-0.19
$0.37
Q1 24
$-0.22
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APYX
APYX
SFST
SFST
Cash + ST InvestmentsLiquidity on hand
$31.7M
Total DebtLower is stronger
$37.5M
Stockholders' EquityBook value
$14.5M
$368.7M
Total Assets
$66.8M
$4.4B
Debt / EquityLower = less leverage
2.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APYX
APYX
SFST
SFST
Q4 25
$31.7M
Q3 25
$25.1M
Q2 25
$29.3M
Q1 25
$31.0M
Q4 24
$31.7M
Q3 24
$28.0M
Q2 24
$32.7M
Q1 24
$37.3M
Total Debt
APYX
APYX
SFST
SFST
Q4 25
$37.5M
Q3 25
$37.5M
Q2 25
$37.5M
Q1 25
$37.5M
Q4 24
$37.5M
Q3 24
$37.5M
Q2 24
Q1 24
Stockholders' Equity
APYX
APYX
SFST
SFST
Q4 25
$14.5M
$368.7M
Q3 25
$5.8M
$356.3M
Q2 25
$7.3M
$345.5M
Q1 25
$10.5M
$337.6M
Q4 24
$14.2M
$330.4M
Q3 24
$11.0M
$326.5M
Q2 24
$14.7M
$318.7M
Q1 24
$20.3M
$315.3M
Total Assets
APYX
APYX
SFST
SFST
Q4 25
$66.8M
$4.4B
Q3 25
$57.4M
$4.4B
Q2 25
$58.2M
$4.3B
Q1 25
$60.2M
$4.3B
Q4 24
$64.8M
$4.1B
Q3 24
$60.7M
$4.2B
Q2 24
$65.4M
$4.1B
Q1 24
$70.7M
$4.1B
Debt / Equity
APYX
APYX
SFST
SFST
Q4 25
2.58×
Q3 25
6.41×
Q2 25
5.17×
Q1 25
3.57×
Q4 24
2.64×
Q3 24
3.40×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APYX
APYX
SFST
SFST
Operating Cash FlowLast quarter
$-2.5M
$30.5M
Free Cash FlowOCF − Capex
$-2.8M
$29.9M
FCF MarginFCF / Revenue
-14.6%
93.8%
Capex IntensityCapex / Revenue
1.4%
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-9.1M
$62.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APYX
APYX
SFST
SFST
Q4 25
$-2.5M
$30.5M
Q3 25
$-3.5M
$14.5M
Q2 25
$-1.2M
$10.5M
Q1 25
$-702.0K
$7.6M
Q4 24
$-2.9M
$25.6M
Q3 24
$-4.4M
$26.3M
Q2 24
$-4.3M
$4.0M
Q1 24
$-6.3M
$-2.9M
Free Cash Flow
APYX
APYX
SFST
SFST
Q4 25
$-2.8M
$29.9M
Q3 25
$-4.1M
$14.4M
Q2 25
$-1.5M
$10.4M
Q1 25
$-757.0K
$7.4M
Q4 24
$-3.2M
$24.8M
Q3 24
$-4.6M
$26.1M
Q2 24
$-4.6M
$3.9M
Q1 24
$-6.4M
$-3.2M
FCF Margin
APYX
APYX
SFST
SFST
Q4 25
-14.6%
93.8%
Q3 25
-31.5%
46.3%
Q2 25
-13.2%
36.3%
Q1 25
-8.0%
28.1%
Q4 24
-22.4%
98.2%
Q3 24
-40.0%
110.0%
Q2 24
-38.0%
16.8%
Q1 24
-62.2%
-15.0%
Capex Intensity
APYX
APYX
SFST
SFST
Q4 25
1.4%
1.8%
Q3 25
4.0%
0.3%
Q2 25
2.3%
0.3%
Q1 25
0.6%
0.5%
Q4 24
1.7%
3.1%
Q3 24
1.3%
0.8%
Q2 24
2.4%
0.4%
Q1 24
0.3%
1.3%
Cash Conversion
APYX
APYX
SFST
SFST
Q4 25
Q3 25
1.67×
Q2 25
1.59×
Q1 25
1.44×
Q4 24
Q3 24
6.01×
Q2 24
1.32×
Q1 24
-1.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons